| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief R&D Strategy Officer | Chief Scientific Officer
1 company
Liu David Y is a Chief R&D Strategy Officer at Protagonist Therapeutics, Inc. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $10.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2021 | PTGX Protagonist Therapeutics, Inc | Chief Scientific Officer | Sale+OE | 14,779 | $47.56 | $702,889.24 | -20.2% | -26.0% | -79.0% | |
| Aug 6, 2019 | PTGX Protagonist Therapeutics, Inc | Chief Scientific Officer | Sell | 3,395 | $8.85 | $30,044.05 | -6.4% | - | - | |
| Mar 1, 2019 | PTGX Protagonist Therapeutics, Inc | Chief Scientific Officer | Sell | 810 | $8.03 | $6,504.30 | -1.6% | - | - | |
| Feb 6, 2019 | PTGX Protagonist Therapeutics, Inc | Chief Scientific Officer | Sell | 3,821 | $7.74 | $29,561.55 | -9.4% | - | - | |
| Mar 12, 2018 | PTGX Protagonist Therapeutics, Inc | Chief Scientific Officer | Sale+OE | 3,500 | $21.29 | $74,499.95 | -18.9% | - | - | |
| Mar 2, 2018 | PTGX Protagonist Therapeutics, Inc | Chief Scientific Officer | Sale+OE | 875 | $20.00 | $17,500.00 | -6.2% | - | - | |
| Jan 16, 2018 | PTGX Protagonist Therapeutics, Inc | Chief Scientific Officer | Sale+OE | 875 | $20.00 | $17,500.00 | -18.6% | - | - | |
| Dec 18, 2017 | PTGX Protagonist Therapeutics, Inc | Chief Scientific Officer | Sale+OE | 875 | $20.00 | $17,500.00 | -18.6% | - | - | |
| Nov 30, 2017 | PTGX Protagonist Therapeutics, Inc | Chief Scientific Officer | Sale+OE | 875 | $20.00 | $17,500.00 | -18.6% | - | - | |
| Nov 13, 2017 | PTGX Protagonist Therapeutics, Inc | Chief Scientific Officer | Sale+OE | 7,000 | $16.97 | $118,761.30 | -47.8% | - | - |